Kuldip Gill Appointed Head of Research and Development

VANCOUVER, Feb. 6, 2019 /CNW/ - Geyser Brands Inc (TSX-V: GYSR) (the "Company") is pleased to announce the appointment of Kuldip Gill as head of research and development.

With over 35+ years of experience Kuldip Gill built the largest manufacturing facility in the lower mainland complete with R&D, analytical and Quality control labs approved by both FDA and Health Canada in Surrey, British Columbia. He has to date created over 3500 formulas and with 35+ years of extensive formulation experience and products that have been sold all over the world, most notably creating Lakota pain relief gel.  Experience and proven track records in personal care, natural and non-prescription health products and pharmaceutical OTC products with strongly marketable formulations for both DIN and Natural Product Number (NPN). Mr. Gill has a medical background which he utilizes in his R&D. projects.

Dedicated, motivated and detailed oriented Mr. Gill will be working with a team of qualified people to oversee new formulations and work on perfecting bioavailability of consumer products that Geyser anticipates to offering to the public in the near term.

Andreas Thatcher commented "Kuldip's track record speaks for itself. His depth of knowledge and experience with ingredients and formulations brings world-class products to the industry." Mr. Gill added "Geyser Brands is a company fully committed to leading the hemp-based health product industry. I look forward to working with the team."

The Company came to trade on the TSX Venture Exchange under the symbol "GYSR" at the end of December. The Company is funded and enjoys the lowest market capitalization of any cannabis company with a Health Canada cultivation license.

ABOUT GEYSER BRANDS

Geyser Brands Inc builds health-based hemp CBD consumer products in the Nutraceutical, Cosmetics, Food & Beverage and Pet sectors world-wide. R&D investment in NanoFusion, a proprietary all-natural nanotechnology, delivers creams, beverages, baked goods and tincture formulations with superior bio-availability and water-solubility. Geyser Brands is a Health Canada approved Licensed Producer in Port Coquitlam B.C.

On Behalf of the Board of Directors

"Andres Thatcher"

____________________________________
Andreas Thatcher
Director and CEO

THIS NEWS RELEASE, PROVIDED PURSUANT TO APPLICABLE CANADIAN REQUIREMENTS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS ABSENT REGISTRATION OR APPLICABLE EXEMPTION FROM REGISTRATION REQUIREMENTS.

Cautionary and Forward-Looking Statements

This news release contains forward‐looking statements and forward‐looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward‐looking statements or information. Forward‐looking statements and information are often, but not always, identified by the use of words such as "appear", "seek", "anticipate", "plan", "continue", "estimate", "approximate", "expect", "may", "will", "project", "predict", "potential", "targeting", "intend", "could", "might", "should", "believe", "would" and similar expressions.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward‐looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the risks associated with the marijuana industry in general such as operational risks in growing; competition; incorrect assessment of the value and potential benefits of various transactions; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and government regulations. Accordingly, readers should not place undue reliance on the forward‐looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

SOURCE Geyser Brands Inc.